Inventor profile of:

Eric Hedrick

City:

Summit, New Jersey

Country:

United States

Published Applications:

25

Last publication date:

2025-04-24

Top Assignees for applications by Eric Hedrick

The entities that hold a legal rights for patent applications filed by inventor Hedrick Eric:

Recent patent applications by Hedrick Eric

Eric Hedrick from Summit, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-04-24
US20250127781A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#2 | 2021-11-25
US20210361657A1
Human necessities

USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)

#3 | 2020-01-09
US20200009176A1
Human necessities

TREATMENT OF LEUKEMIA VIA THE ADMINISTRATION OF DOT1L INHIBITOR PINOMETOSTAT

#4 | 2019-03-14
US20190076455A1
Human necessities

TREATMENT OF LEUKEMIA VIA THE ADMINISTRATION OF DOT1L INHIBITOR PINOMETOSTAT

#5 | 2018-10-04
US20180280395A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#6 | 2018-09-13
US20180256581A1
Human necessities

Use of inhibitors of bruton's tyrosine kinase (Btk)

#7 | 2018-02-08
US20180036313A1
Human necessities

Use of inhibitors of Bruton's tyrosine kinase (Btk)

#8 | 2018-01-18
US20180015091A1
Human necessities

Use of inhibitors of Bruton's tyrosine kinase (Btk)

#9 | 2017-09-21
US20170266186A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#10 | 2017-02-09
US20170035762A1
Human necessities

Use of inhibitors of Bruton'S tyrosine kinase (Btk)

#11 | 2016-11-10
US20160324859A1
Human necessities

Use of inhibitors of bruton's tyrosine kinase (BTK)

#12 | 2016-10-13
US20160296548A1
Human necessities

Methods for treating cancer

#13 | 2016-06-23
US20160175312A1
Human necessities

Use of inhibitors of bruton's tyrosine kinase (Btk)

#14 | 2015-01-29
US20150031711A1
Chemistry; metallurgy

Use of inhibitors of Bruton's tyrosine kinase (Btk)

#15 | 2015-01-29
US20150031710A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#16 | 2014-10-09
US20140303191A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#17 | 2014-07-10
US20140194446A1
Chemistry; metallurgy

Use of inhibitors of bruton's tyrosine kinase (BTK)

#18 | 2013-11-21
US20130310402A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#19 | 2013-10-17
US20130273030A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#20 | 2013-08-08
US20130202611A1
Chemistry; metallurgy

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#21 | 2013-08-01
US20130195852A1
Human necessities

Use of inhibitors of Bruton's tyrosine kinase (Btk)

#22 | 2012-07-19
US20120183535A1
Human necessities

Use of inhibitors of bruton's tyrosine kinase (Btk)

#23 | 2012-04-26
US20120100138A1
Human necessities

THE USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#24 | 2012-04-12
US20120087915A1
Human necessities

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

#25 | 2010-10-21
US20100266589A1
Chemistry; metallurgy

ADJUVANT CANCER THERAPY

InventorID:

364744 ⎘